Wird geladen...
Propranolol and breast cancer—a work in progress
The non-selective beta-blocker propranolol is a leading candidate for repurposing as a novel anti-cancer agent. Emerging evidence, including human data, suggests that there are multiple mechanisms of action particularly relevant to breast cancer. This editorial reviews a number of recent studies tha...
Gespeichert in:
| Veröffentlicht in: | Ecancermedicalscience |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Cancer Intelligence
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6027968/ https://ncbi.nlm.nih.gov/pubmed/30034523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2018.ed82 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|